Mignar 25 Tablet is a prescription-only medication containing Miglitol, a synthetic sugar analog, in a strength of 25 milligrams. It is indicated for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control. Mignar 25 Tablet works by inhibiting the breakdown of complex carbohydrates in the small intestine, thereby reducing the increase in postprandial blood glucose levels. This delay in carbohydrate absorption helps to prolong the normal absorption of nutrients and reduces the postprandial hyperglycemia. The medication should be taken orally, usually before meals, as directed by the healthcare provider. The recommended starting dose is 25 milligrams three times a day, with the possibility of dose adjustment based on glycemic response. It is essential to monitor blood glucose levels regularly to adjust the dosage and optimize glycemic control. Mignar 25 Tablet should be used with caution in patients with a history of gastrointestinal disorders, as it may cause gastrointestinal adverse reactions.